News Sanofi invests in new Canadian vaccine manufacturing plant Sanofi is investing 350 million euros in a new vaccine manufacturing facility at its Canadian headquarters in Toronto.
News Call for new restrictions on UK vaccine prices Proposals also include fresh attack on drug prices
News Prokarium raises $10m for 'game changer' synthetic bio vacci... UK company Prokarium has raised $10 million to develop groundbreaking synthetic biology techniques to create a new generation of vaccines, which could be taken orally, and not have to be ke
News Ex-GSK chiefs Witty and Slaoui join biotech investors Former GSK CEO Sir Andrew Witty, and his former drug development chief, Moncef Slaoui have both lined up new jobs as life science investors.
News Tipped to hit $1bn, GSK’s Shingrix gains committee approval GlaxoSmithKline’s shingles vaccine Shingrix has gained the unanimous backing of an FDA advisory committee.
News Macmillan lends support to UK prostate cancer data project Prostate Progress, a data-powered project to find better tests, treatments, and care for prostate cancer, is expanding via an alliance with Macmillan.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.